2Webster D, Rennie RP, Brosnikoff CL, et al. Methicillin-resistant Staphylococcus aureus with reduced susceptibili-ty to vancomycin in Canada [J]. Diagn Microbiol InfactDis,2007,57(2). :177-181.
3Shorr AF. Epidemioology of staphyloccal resistance[J].Clin Infact Dis,2007,45(Suppl3). :S171-176.
4Tiwari HK, Das AK, Sapkota D, et al. Methicillin-resist-ant Staphylococcus aureus: prevalence and antibiogram ina tertiary care hospital in western Nepal[J]. J Infect Dev,2009,3(9).:681-684.
5Nafsika H. Georgopapadakou. Infectious disease 2001 : drugResistance, new drugs [ J]. Drug Resistance Updates,2002,5:181-191.
6Chang S,Sievert DM, Heqeman JC,et al. Infection withvancomycin-resistant staphylococcus aureus containingthe vanA resistance gene [J]. N Engl J Med,2003,348(14).:1342-1347.
9Gupta V,Datta P,Rani H,et al. Inducible clindamycin re-sistance in Staphylococcus aureus:a study from North In-dia[J]. J Postgrad Med,2009,55(3). :176-179.
10Lecaillon E,Gueudet P,Wooton M,et al. Endemic hetero-resistant glycopeptide intermediate Staphylcoccus aureus(hGISA). comprising unrelated clonal types and not asvso-ciated with vancomycin therapy[J]. Pathol Biol (Paris).,2002,50(9).:525-529.
7Chambers HF.Methicillin resistance in staphylococci:molecular and biochemical basis and clinical implications[J].Clin Microbiol Rev,1997,(10):781-791.
8Brown DF.Detection of methicillin/oxacillin resistance in staphylococci[J].J Antimicrob Chemother,2001,(48) Suppl:S1,S65-S70.
9Skov R,Smyth R,Clausen M,et al.Evaluation of a cefoxitin 30μg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus[J].J Antimicrob Chemother,2003,(52):204-207.
10National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[M].Fourteenth informational supplement.Pennsylvania:NCCLS,2004.39-47.
